Mid-term results of percutaneous ventricular septal defect closure with Amplatzer Duct Occluder-II in children


PAMUKÇU Ö. , NARİN N. , BAYKAN A. , SUNKAK S. , TAŞCI O. , ÜZÜM K.

CARDIOLOGY IN THE YOUNG, cilt.27, ss.1726-1731, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 27 Konu: 9
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1017/s104795111700107x
  • Dergi Adı: CARDIOLOGY IN THE YOUNG
  • Sayfa Sayıları: ss.1726-1731

Özet

Aim The aim of this study was to share the mid-term results of percutaneous ventricular septal defect closure using Amplatzer Duct Occluder-II in children. Background Nowadays, percutaneous ventricular septal defect closure is accepted as an alternative to surgery, but so far no ideal device has been developed for this procedure. Methods In the study centre, between April, 2011 and October, 2016, the ventricular septal defect of 49 patients was closed percutaneously using the Amplatzer Duct Occluder-II device, and seven of them were < 1 year old. Results The mean age of patients was 86.8 +/- 52.6 months. The mean weight of the patients was 24.3 +/- 16 kg. The mean diameter of the defect was 3.7 +/- 1.4 mm. Mean fluoroscopy time and total procedure time were 3.7 +/- 19.3 and 74.1 +/- 27 minutes, respectively. The types of ventricular septal defects were muscular in six patients, and were perimembranous in the rest of them. We did not face any major complications during the procedure, but one patient was admitted with a complete atrioventricular block in the 6th month of follow-up. The total follow-up period was 66 months. Conclusion To our knowledge, our study includes the largest series of paediatric patients whose ventricular septal defect was closed using Amplatzer Duct Occluder-II percutaneously. When the complications during the 66-month follow-up period are taken into consideration, we can state that Amplatzer Duct Occluder-II is a safe and effective device, even in infants aged < 1 year.